What type of therapy is commonly used to treat lens induced uveitis?

Lens-induced uveitis is a condition that occurs when proteins from the lens of the eye leak into the anterior chamber following cataract formation or lens rupture, prompting an inflammatory response. Topical NSAIDs (non-steroidal anti-inflammatory drugs) are often used in these cases because they specifically target inflammation in the eye while minimizing systemic side effects.

Topical NSAIDs help to reduce pain and inflammation associated with uveitis and have a fast onset of action due to their direct application to the affected area. These medications are effective for controlling the inflammatory response and are commonly preferred as a part of the therapeutic regimen for lens-induced uveitis.

In contrast, other types of therapies may not be as effective or appropriate in this specific scenario. For instance, while oral corticosteroids can reduce inflammation systemically, they may not provide the localized control needed in lens-induced uveitis and carry a risk of significant side effects. Topical antihistamines are typically used for allergic conjunctivitis rather than uveitis, while systemic antibiotics would be indicated only for bacterial infections, not for inflammatory conditions like uveitis. Therefore, the choice of topical NSAIDs aligns with the goal of managing uveitis effectively by directly addressing inflammation in the ocular tissues.